Volume indicators and left ventricular mass during aggressive volume management in patients on thrice-weekly hemodialysis

Nephron - Clinical Practice

Volumn 113, Issue 4, 2009, Pages

  Goldfarb Rumyantzev, Alexander S ^a   Chelamcharla, Madhukar ^b   Bray, Bruce E ^b   Leypoldt, John K ^b   Lavasani, Iran ^b   Nelson, Natalia ^b   Lavasani, Tooran ^b   Baird, Bradley ^b   Cheung, Alfred K ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Salt Lake City Health Care System   (United States)

Author keywords

Bioelectric impedance; Brain natriuretic peptide; Echocardiography; Hemodialysis; Hypervolemia; Left ventricular hypertrophy; Ultrasound; Vena cava

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; FLUID THERAPY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; INFERIOR CAVA VEIN; MALE; PRIORITY JOURNAL; VEIN DIAMETER;

ADULT; AGED; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ORGAN SIZE; PROGNOSIS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 68549107924     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235252     Document Type: Article

References (34)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, et al: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
2. Foley RN, Parfrey PS, Kent GM, Harnett JD, et al: Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 2000; 11: 912-916.
3. Kannel WB, Gordon T, Offutt D: Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham Study. Ann Intern Med 1969; 71: 89-105.
4. Amann K, Rychlik I, Miltenberger-Milteny G, Ritz E: Left ventricular hypertrophy in renal failure. Kidney Int 1998; 68(suppl):S78-S85.
5. Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, et al: Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 29: 641-647.
6. Foley RN, Parfrey PS, Kent GM, Harnett JD, et al: Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 1998; 54: 1720-1725.
7. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9:S16-S23.
8. Rocco MV, Yan G, Heyka RJ, Benz R, et al: Risk factors for hypertension in chronic hemodialysis patients: Baseline data from the HEMO study. Am J Nephrol 2001; 21: 280-288.
9. Wizemann V, Schilling M: Dilemma of assessing volume state - the use and the limitations of a clinical score. Nephrol Dial Transplant 1995; 10: 2114-2117.
10. de Zeeuw D, Janssen WM, de Jong PE: Atrial natriuretic factor: Its (patho)physiological significance in humans. Kidney Int 1992; 41: 1115-1133.
11. Naganuma T, Sugimura K, Wada S, Yasumoto R, et al: The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 2002; 22: 437-444.
12. Sun SS, Chumlea WC, Heymsfield SB, Lukaski HC, et al: Development of bioelectrical impedance analysis prediction equations for body composition with the use of a multicomponent model for use in epidemiologic surveys. Am J Clin Nutr 2003; 77: 331-340.
13. Kushner RF, de Vries PM, Gudivaka R: Use of bioelectrical impedance analysis measurements in the clinical management of patients undergoing dialysis. Am J Clin Nutr 1996; 64: 503S-509S.
14. Cooper BA, Aslani A, Ryan M, Zhu FY, et al: Comparing different methods of assessing body composition in end-stage renal failure. Kidney Int 2000; 58: 408-416.
15. Katzarski K, Charra B, Laurent G, Lopot F, et al: Multifrequency bioimpedance in assessment of dry weight in haemodialysis. Nephrol Dial Transplant 1996; 11(suppl 2):20-23.
16. Chamney PW, Kramer M, Rode C, Kleinekofort W, et al: A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int 2002; 61: 2250-2258.
17. Chanchairujira T, Mehta RL: Assessing fluid change in hemodialysis: whole body versus sum of segmental bioimpedance spectroscopy. Kidney Int 2001; 60: 2337-2342.
18. Chumlea WC, Guo SS, Cockram DB, Siervogel RM: Mechanical and physiologic modifiers and bioelectrical impedance spectrum determinants of body composition. Am J Clin Nutr 1996; 64: 413S-422S.
19. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, et al: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
20. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
21. Levy D, Savage DD, Garrison RJ, Anderson KM, et al: Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol 1987; 59: 956-960. (Pubitemid 17074242)
22. Moreno FL, Hagan AD, Holmen JR, Pryor TA, et al: Evaluation of size and dynamics of the inferior vena cava as an index of rightsided cardiac function. Am J Cardiol 1984; 53: 579-585.
23. Agarwal R: Role of home blood pressure monitoring in hemodialysis patients. Am J Kidney Dis 1999; 33: 682-687.
24. Pickering TG: Should we be evaluating blood pressure dipping status in clinical practice? J Clin Hypertens (Greenwich) 2005; 7: 178-182.
25. Kario K, Schwartz JE, Pickering TG: Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of alpha-adrenergic blocker, doxazosin: Results from the HALT study. Hypertension 2000; 35: 787-794.
26. Chen YC, Chen HH, Yeh JC, Chen SY: Adjusting dry weight by extracellular volume and body composition in hemodialysis patients. Nephron 2002; 92: 91-96.
27. Edelman IS, Leibman J: Anatomy of body water and electrolytes. Am J Med 1959; 27: 256-277.
28. Jaeger JQ, Mehta RL: Assessment of dry weight in hemodialysis: An overview. J Am Soc Nephrol 1999; 10: 392-403.
29. Cannella G, Paoletti E, Delfino R, Peloso G, et al: Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 1993; 44: 881-886.
30. Harnett JD, Kent GM, Barre PE, Taylor R, et al: Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994; 4: 1486-1490.
31. Ozkahya M, Toz H, Qzerkan F, Duman S, et al: Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002; 15: 655-660.
32. Ozkahya M, Ok E, Cirit M, Aydin S, et al: Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 1998; 13: 1489-1493.
33. Culleton BF, Walsh M, Klarenbach SW, Mortis G, et al: Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA 2007; 298: 1291-1299.
34. Kong CH, Farrington K: Determinants of left ventricular hypertrophy and its progression in high-flux haemodialysis. Blood Purif 2003; 21: 163-169.